secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2022-03-07T23:59:59+00:00
Accession:  0001193125-22-067138
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED EVP Jed Kennedy retires Apr 1, 2022; serves as Special Advisor to Apr 2023
--------------------------------------------------------------------------------

- John 'Jed' E. Kennedy, Group EVP of Advanced Endoscopic Technologies, QA/RA, Distribution and Customer Service, retires April 1, 2022.
- Kennedy to serve as Special Advisor from Apr 1, 2022 through Apr 1, 2023 with salary $392,188 plus average of 2020 and 2021 bonuses.
- Advanced Endoscopic Technologies to report to Bill Peters, who becomes President Advanced Surgical and AET.
- Brent Lalomia, VP of QA/RA, reports directly to CEO Curt Hartman; other duties reassigned.
- Equity awards continue vesting through Apr 1, 2023; awards with later vesting dates forfeited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000119312522067138/0001193125-22-067138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000119312522067138/d288631d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-067138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer